Virtus ETF Advisers’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,278
| Closed | -$101K | – | 491 |
|
|
2023
Q4 | $101K | Sell |
4,278
-7,065
| -62% | -$167K | 0.06% | 352 |
|
|
2023
Q3 | $169K | Sell |
11,343
-1,127
| -9% | -$16.8K | 0.1% | 296 |
|
|
2023
Q2 | $137K | Buy |
+12,470
| New | +$137K | 0.08% | 324 |
|
|
2019
Q4 | – | Sell |
-40,232
| Closed | -$206K | – | 518 |
|
|
2019
Q3 | $206K | Sell |
40,232
-2,241
| -5% | -$11.5K | 0.04% | 245 |
|
|
2019
Q2 | $304K | Buy |
42,473
+11,526
| +37% | +$82.5K | 0.06% | 207 |
|
|
2019
Q1 | $411K | Sell |
30,947
-3,490
| -10% | -$46.4K | 0.87% | 37 |
|
|
2018
Q4 | $271K | Sell |
34,437
-1,683
| -5% | -$13.2K | 0.05% | 145 |
|
|
2018
Q3 | $400K | Sell |
36,120
-25,831
| -42% | -$286K | 0.04% | 161 |
|
|
2018
Q2 | $831K | Sell |
61,951
-31,366
| -34% | -$421K | 0.73% | 19 |
|
|
2018
Q1 | $1.21M | Buy |
93,317
+50,832
| +120% | +$660K | 1.05% | 19 |
|
|
2017
Q4 | $391K | Buy |
+42,485
| New | +$391K | 0.49% | 59 |
|